18 research outputs found
The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature
A grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.Background
Probiotics have generated intensive research interest in recent years as a novel mode of treatment for physical and mental illness. Nevertheless, the anxiolytic potential of probiotics remains unclear. The present systematic review and meta-analysis aimed to evaluate the clinical and preclinical (animal model) evidence regarding the effect of probiotic administration on anxiety.
Methods
The PubMed, PsycINFO, and Web of Science databases were reviewed for preclinical and clinical studies that met the defined inclusion and exclusion criteria. The effects of probiotics on anxiety-like behavior and symptoms of anxiety were analyzed by meta-analyses. Separate subgroup analyses were conducted on diseased versus healthy animals, specific preclinical probiotic species, and clinical versus healthy human samples.
Results
Data were extracted from 22 preclinical studies (743 animals) and 14 clinical studies (1527 individuals). Overall, probiotics reduced anxiety-like behavior in animals (Hedges’ g = -0.47, 95% CI -0.77 –-0.16, p = 0.004). Subgroup analyses revealed a significant reduction only among diseased animals. Probiotic species-level analyses identified only Lactobacillus (L.) rhamnosus as an anxiolytic species, but these analyses were broadly under-powered. Probiotics did not significantly reduce symptoms of anxiety in humans (Hedges’ g = -0.12, 95% CI -0.29–0.05, p = 0.151), and did not differentially affect clinical and healthy human samples.
Conclusions
While preclinical (animal) studies suggest that probiotics may help reduce anxiety, such findings have not yet translated to clinical research in humans, perhaps due to the dearth of extant research with clinically anxious populations. Further investigation of probiotic treatment for clinically relevant anxiety is warranted, particularly with respect to the probiotic species L. rhamnosus
The depressogenic potential of added dietary sugars
Added sugars are ubiquitous in contemporary Western diets. Although excessive sugar consumption is now
robustly associated with an array of adverse health consequences, comparatively little research has thus far
addressed its impact on the risk of mental illness. But ample evidence suggests that high-dose sugar intake can
perturb numerous metabolic, inflammatory, and neurobiological processes. Many such effects are of particular
relevance to the onset and maintenance of depressive illness, among them: systemic inflammation, gut microbiota
disruption, perturbed dopaminergic reward signaling, insulin resistance, oxidative stress, and the generation
of toxic advanced glycation end-products (AGEs). Accordingly, we hypothesize that added dietary sugars
carry the potential to increase vulnerability to major depressive disorder, particularly at high levels of consumption.
The present paper: (a) summarizes the existing experimental and epidemiological research regarding
sugar consumption and depression vulnerability; (b) examines the impact of sugar ingestion on known depressogenic
physiological processes; and (c) outlines the clinical and theoretical implications of the apparent
sugar-depression link. We conclude that the extant literature supports the hypothesized depressogenic impact of
added dietary sugars, and propose that an improved understanding of the effects of sugar on body and mind may
aid in the development of novel therapeutic and preventative measures for depression
Advances in understanding and treating ADHD
Attention deficit hyperactivity disorder (ADHD) is a neurocognitive behavioral developmental disorder most commonly seen in childhood and adolescence, which often extends to the adult years. Relative to a decade ago, there has been extensive research into understanding the factors underlying ADHD, leading to far more treatment options available for both adolescents and adults with this disorder. Novel stimulant formulations have made it possible to tailor treatment to the duration of efficacy required by patients, and to help mitigate the potential for abuse, misuse and diversion. Several new non-stimulant options have also emerged in the past few years. Among these, cognitive behavioral interventions have proven popular in the treatment of adult ADHD, especially within the adult population who cannot or will not use medications, along with the many medication-treated patients who continue to show residual disability
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene associated with ALS. Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia (SPG10) and Charcot-Marie-Tooth type 2 (CMT2). In contrast, ALS-associated mutations are primarily located at the C-terminal cargo-binding tail domain and patients harboring loss-of-function mutations displayed an extended survival relative to typical ALS cases. Taken together, these results broaden the phenotype spectrum resulting from mutations in KIF5A and strengthen the role of cytoskeletal defects in the pathogenesis of ALS.Peer reviewe
The acute side effects of bright light therapy: a placebo-controlled investigation.
Despite the emergence of numerous clinical and non-clinical applications of bright light therapy (LT) in recent decades, the prevalence and severity of LT side effects have not yet been fully explicated. A few adverse LT effects-headache, eye strain, irritability, and nausea-have been consistently reported among depressed individuals and other psychiatric cohorts, but there exists little published evidence regarding LT side effects in non-clinical populations, who often undergo LT treatment of considerably briefer duration. Accordingly, in the present study we examined, in a randomized sample of healthy young adults, the acute side effects of exposure to a single 30-minute session of bright white light (10,000 lux) versus dim red light (< 500 lux). Across a broad range of potential side effects, repeated-measures analyses of variance revealed no significant group-by-time (Pre, Post) interactions. In other words, bright light exposure was not associated with a significantly higher incidence of any reported side effect than was the placebo control condition. Nevertheless, small but statistically significant increases in both eye strain and blurred vision were observed among both the LT and control groups. Overall, these results suggest that the relatively common occurrence of adverse side effects observed in the extant LT literature may not fully extend to non-clinical populations, especially for healthy young adults undergoing LT for a brief duration
Handbook of Research Methods in Clinical Psychology
The Handbook of Research Methods in Clinical Psychology presents a comprehensive and contemporary treatment of research methodologies used in clinical psychology. Topics discussed include experimental and quasi-experimental designs, statistical analysis, validity, ethics, cultural diversity, and the scientific process of publishing. Written by leading researchers, the chapters focus on specific applications of research into psychopathology, assessment and diagnosis, therapy, and interventions for both child and adult populations. Special attention is also given to research into professional issues, prevention, and promotion. Research vignettes describe exemplary projects illustrating the essential elements of the research topics. In addition, the editors outline a research agenda for clinical psychologists that demonstrates the exciting future for the field. This handbook coherently illustrates the range of research methodologies used in clinical psychology and is a vital resource for both students and scholars who wish to expand their knowledge
Percentage of Side Effects Reported for Dim Red and Bright White Light at Post-Treatment.
<p>Percentage of Side Effects Reported for Dim Red and Bright White Light at Post-Treatment.</p
Flow and selection of preclinical studies.
<p>Flow and selection of preclinical studies.</p
Forest plot of preclinical studies investigating the effect of probiotics on anxiety-like behavior.
<p>SMD = Standardized mean difference; CI = Confidence interval. An aggregate SMD is displayed for each experimental group. Measure-specific SMDs can be viewed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0199041#pone.0199041.s003" target="_blank">S1 Fig</a>.</p